This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: University of South Florida. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: The Innovative Contributions of Andrew McGill
Introduction
Andrew McGill is a notable inventor based in Tampa, FL, who has made significant strides in the field of medical technology. His work primarily focuses on developing innovative solutions for treating viral infections, particularly those caused by coronaviruses. With a keen interest in advancing healthcare, McGill has contributed to the scientific community through his research and patent.
Latest Patents
Andrew McGill holds a patent for a groundbreaking invention titled "Composition and method for treating COVID-19." This patent presents a nanosystem and methods for treating, including prophylactically, coronavirus infections, such as those caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The nanosystem may comprise a single or a combination of therapeutic agents, which can be encapsulated in a nanoparticle with a targeting moiety directed at the specific coronavirus. For CoV-2 infections, at least one therapeutic agent, such as the dual DPP4/ACE2 inhibitor sitagliptin, may be encapsulated within a nanoparticle that includes a fatty acid like linoleic acid as the targeting moiety. Administration can occur intranasally prior to infection for prophylactic treatment or post-infection for the treatment of the viral infection. McGill's innovative approach has the potential to significantly impact the management of COVID-19.
Career Highlights
Andrew McGill is affiliated with the University of South Florida, where he continues to engage in research and development in the field of medical technology. His dedication to innovation and improving healthcare outcomes is evident in his work and contributions to the scientific community.
Collaborations
Some of Andrew McGill's notable coworkers include Subhra Mohapatra and Shyam S Mohapatra, who have collaborated with him on various research projects. Their combined expertise enhances the quality and impact of their work in the field.
Conclusion
In summary, Andrew McGill is an accomplished inventor whose work in developing a nanosystem for treating COVID-19 showcases his commitment to advancing medical technology. His contributions have the potential to make a significant difference in the fight against viral infections.